Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608022

Concept	2021-04-01 to 2021-09-30	2021-04-01 to 2021-09-30	2021-04-01 to 2021-09-30	2021-04-01 to 2021-09-30	2021-04-01 to 2021-09-30
Statement of income
Statement of income
Net sales
Net sales	28,504,000,000 JPY	-26,000,000 JPY	2,884,000,000 JPY	28,477,000,000 JPY	25,619,000,000 JPY
Operating revenue
Operating expenses
Cost of sales
Cost of sales	—	—	—	15,051,000,000 JPY	—
Selling, general and administrative expenses	—	—	—	10,768,000,000 JPY	—
Operating expenses
Research and development expenses	—	—	—	1,941,000,000 JPY	—
Operating profit (loss)	3,000,000,000 JPY	-342,000,000 JPY	202,000,000 JPY	2,657,000,000 JPY	2,797,000,000 JPY
Gross profit (loss)	—	—	—	13,426,000,000 JPY	—
Ordinary profit (loss)	—	—	—	2,743,000,000 JPY	—
Gross profit
Non-operating income
Interest income	—	—	—	0 JPY	—
Non-operating income
Non-operating income	—	—	—	254,000,000 JPY	—
Financial revenue	—	—	—	—	—
Dividend income	—	—	—	137,000,000 JPY	—
Other	—	—	—	65,000,000 JPY	—
Non-operating expenses
Interest expenses	—	—	—	29,000,000 JPY	—
Non-operating expenses
Selling, general and administrative expenses
Extraordinary losses	—	—	—	6,882,000,000 JPY	—
Impairment losses	—	—	—	5,921,000,000 JPY	—
Other	—	—	—	961,000,000 JPY	—
Non-operating expenses
Non-operating expenses	—	—	—	168,000,000 JPY	—
Financial expenses	—	—	—	—	—
Other	—	—	—	30,000,000 JPY	—
Profit (loss) before income taxes	—	—	—	-4,139,000,000 JPY	—
Income taxes - current	—	—	—	117,000,000 JPY	—
Extraordinary losses
Income taxes - deferred	—	—	—	-1,460,000,000 JPY	—
Income taxes	—	—	—	-1,342,000,000 JPY	—
Profit (loss)	—	—	—	-2,796,000,000 JPY	—